Category: Somaderm

BOSTON (Reuters) – Prosecutors on Thursday will present their closing arguments in the trial of the wealthy founder of Pharmaceutical company Insys Therapeutics Inc and four colleagues accused of contributing to the U.S. opioid epidemic by bribing doctors to prescribe an addictive fentanyl spray. FILE PHOTO: John Kapoor (R), the billionaire founder of Insys Therapeutics […]

Read more

ZURICH (Reuters) – Roche Holding said its effort to expand in gene therapy via the $4.3 billion takeover of Spark Therapeutics remained on track despite failing to get enough votes to clinch the deal and as U.S. regulators continued scrutinizing it. <img title="Roche says $4.3 billion Spark offer still on track for June completion " […]

Read more

<img title="Roche extends Spark offer after getting only 29 percent " alt="Roche extends Spark offer after getting only 29 percent " src="https://s2.reutersmedia.net/resources/r/?m=02&d=20190403&t=2&i=1372964172&r=LYNXNPEF320AH&w=450" aria-label="The logo of Swiss Pharmaceutical company Roche is seen outside the Shanghai Roche Pharmaceutical Co. Ltd. headquarters in Shanghai May 22, 2014. REUTERS/Aly Song “> The logo of Swiss Pharmaceutical company Roche is […]

Read more

ZURICH (Reuters) – Novartis’s spinoff of its eyecare division Alcon, set for Tuesday April 9, marks the largest Swiss stock deal in a decade and forces a reshuffle of the benchmark Swiss Market Index (SMI) as private bank Julius Baer gets booted out. <img title="Novartis's Alcon spinoff ousts Baer from Swiss benchmark SMI " alt="Novartis's […]

Read more

India’s drugs control agency has revealed that samples of Johnson & Johnson’s (J&J) baby shampoo taken from two batches had failed the quality test as they contained “harmful ingredients.” The watchdog’s findings come just a few months after Indian authorities launched an investigation into the company’s baby powder to see if it contains cancer-causing asbestos. […]

Read more

NEW YORK (Reuters) – Proxy advisory firms Institutional Shareholder Services and Glass Lewis on Friday said shareholders of Bristol-Myers Squibb Co should vote in favor of the drugmaker’s proposed $74 billion takeover of rival Celgene Corp., which has been opposed by one of its largest investors and an activist hedge fund. <img title="Proxy advisers ISS, […]

Read more

<img title="Proxy advisor ISS backs Bristol takeover of Celgene " alt="Proxy advisor ISS backs Bristol takeover of Celgene " src="https://s3.reutersmedia.net/resources/r/?m=02&d=20190329&t=2&i=1371415512&r=LYNXNPEF2S15Q&w=450" aria-label="FILE PHOTO: Logo of global bioPharmaceutical company Bristol-Myers Squibb is pictured on the blouse of an employee in Le Passage, near Agen, France March 29, 2018. REUTERS/Regis Duvignau/File Photo”> FILE PHOTO: Logo of global bioPharmaceutical […]

Read more

A Vancouver-based advocacy group is under scrutiny by provincial officials after a report emerged claiming that it has been receiving taxpayer money despite promoting an anti-vaccination agenda. It denies being against vaccines. The charity group Health Action Network Society received about a third of its revenue last year from British Columbia’s government last year, CBC […]

Read more

HONG KONG (Reuters) – Chinese traditional Medicine is rapidly expanding worldwide as a key pillar of the country’s Belt and Road initiative, but conservation groups say demand for treatments using animal products is driving a surge in illegal trafficking of wildlife. <img title="As China pushes traditional medicine globally, illegal wildlife trade flourishes " alt="As China […]

Read more

A New Jersey jury on Wednesday cleared Johnson & Johnson (J&J) of liability in a lawsuit by a man who alleged asbestos in the company’s talc-based products, including baby powder, caused his mesothelioma. The jury in Middlesex County Superior Court found that the plaintiff Ricardo Rimondi hadn’t proved he was exposed to asbestos via the […]

Read more